PGNX - Progenics Pharmaceuticals Inc. (PGNX) CEO Mark Baker on Q1 2019 Results - Earnings Call Transcript
Progenics Pharmaceuticals, Inc. (PGNX)
Q1 2019 Earnings Conference Call
May 09, 2019 08:30 AM ET
Company Participants
Melissa Downs - Head of Investor Relations
Mark Baker - Chief Executive Officer
Asha Das - Chief Medical Officer
Bryce Tenbarge - Senior Vice President, Commercial
Pat Fabbio - Executive Vice President & Chief Financial Officer.
Conference Call Participants
Tim Chiang - BTIG
Jennifer Shen - Needham
Jeet Mukherjee - Jefferies
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Progenics Pharmaceuticals First Quarter 2019 Financial Results Conference Call. At this time, all participants are in